You're reading the free version. Trader adds the live tape and alerts.
Start tracking
HALO Sale Disclosure
Connaughton Bernadette · SEC Form 4 · Filed Jul 2, 2026
Sale
Calculated transaction value
$76.39K
Connaughton Bernadette Director
HALO
Transaction date
Jul 1, 2026
Public filing date
Jul 2, 2026
Filing lag
Filed 1 day later
HALO daily price context
Close on/before transaction
$77.01
Jul 1, 2026
First close after public filing
$80.78
Jul 6, 2026
30-day return after filing
+1.84%
Through Aug 3, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 1,000 shares @ $76.39
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001159036-26-000094
Filing cohort
Transactions in this filing
Showing 2 of 2
Trades
2
Issuers
1
Estimated value
$124.65K
Buys / sales
0 / 2
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Halozyme Therapeutics, Inc. HALO Current | Sale | Jul 1, 2026 | $76.39K |
| Halozyme Therapeutics, Inc. HALO | Sale | Jul 1, 2026 | $48.26K |